Abstract Bone metastases are the initial site of progression and account for many of the complications experienced by men with metastatic prostate cancer (PCa), including resistance to therapy. The purpose of our study is to determine whether intravital multiphoton microscopy (iMPM) integrated with a novel mouse model can better inform clinical development of molecular therapeutics targeting bone metastases. iMPM can overcome limitations of existing models by monitoring the dynamic reciprocal cell-cell interplay at the center of PCa bone metastasis. To study PCa-stromal cell interactions and therapy response in bone, we established a humanized neo-bone in the mouse dermis, using grafted electrospun polycaprolactone scaffolds functionalized with human mesenchymal stem cells differentiated to osteoblasts. After in vivo maturation, bone scaffolds served for co-implantation of human fluorescent PCa cells (PC3) followed by multi-parameter iMPM through a body window, including: collagen and bone matrix (second harmonic generation), mineralized matrix (calcein blue), osteoblasts (H2B/mCherry in human mesenchymal stem cells), adipocytes and bone surface (third harmonic generation), blood vessels, stromal phagocytes and osteoclasts (fluorescence-labeled dextran), and PC3 cells (nuclear H2B eGFP with cytoplasmatic DsRed2). Using multi-parameter 3D reconstruction, tumor growth and invasion, reactive remodeling of the stroma and neovessel organization were monitored longitudinally, providing a baseline for evaluating preclinical disease and therapy response. The model provides new insight into PCa bone metastases and will be used to more efficiently develop and prioritize biologically founded therapy for clinical development. Citation Format: Eleonora Dondossola, Stephanie Alexander, Steve Alexander, Boris M. Holzapfel, Christopher J. Logothetis, Dietmar W. Hutmacher, Peter Friedl. A humanized bone model for preclinical monitoring of prostate cancer lesions by intravital multiphoton microscopy. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4941. doi:10.1158/1538-7445.AM2014-4941
Read full abstract